These findings suggest that zinc transporter-mediated pathways play a key role in stromal activation and immune regulation, highlighting <i>SLC39A13</i> as a potential therapeutic target in head and neck squamous cell carcinoma. The gene discussed is SLC39A13; the disease is head and neck squamous cell carcinoma.